Hubert Hackl
Medizinische Universität Innsbruck
H-index: 39
Europe-Austria
Top articles of Hubert Hackl
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts | Oncogene | Andrea Eigentler Florian Handle Silvia Schanung Antonia Degen Hubert Hackl | 2024/1/19 |
Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy | medRxiv | Raphael Gronauer Leonie Madersbacher Pablo Monfort-Lanzas Gabriel Floriani Susanne Sprung | 2024 |
Tumor Mutation Burden beim p53-mutierten Endometriumkarzinom und p53-mutierten serösen high-grade Ovarialkarzinom | Geburtshilfe und Frauenheilkunde | K Steger K Leitner H Hackl H Fiegl B Feroz | 2024/4 |
Neutralizing GDF-15 can overcome anti-PD-(L) 1 resistance in late-stage cancer | Ignacio Melero María de Miguel Luken Guillermo de Velasco Elena Garralda Juan Martin Liberal | 2024/3/7 | |
APRI+ ALBI score outperforms icg and limax in predicting phlf-an international multicenter study | HPB | P Starlinger J Santol S Kim L Gregory AE Kern | 2023/1/1 |
Overcoming docetaxel resistance in advanced prostate cancer: Analysis of statin therapy from a cell-based model to a patient derived prostate cancer tissue micro array | European Urology Open Science | MPJK Brandt O Vakhrusheva H Hackl T Daher K Tagscherer | 2023/10/1 |
Transcriptomic landscapes of effective and failed liver regeneration in humans | JHEP Reports | Patrick Starlinger Laura Brunnthaler Chantal McCabe David Pereyra Jonas Santol | 2023/4/1 |
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment | Nature Communications | Markus Haake Beatrice Haack Tina Schäfer Patrick N Harter Greta Mattavelli | 2023/7/20 |
An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer | Gynecologic Oncology | Verena Wieser Irina Tsibulak Daniel Uwe Reimer Alain Gustave Zeimet Heidelinde Fiegl | 2023/3/1 |
Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP | Frontiers in Immunology | Saskia V Vijver Sarah Danklmaier Lisa Pipperger Raphael Gronauer Gabriel Floriani | 2023/1/19 |
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC | Oncoimmunology | Stefan Koeck Arno Amann Johan Kern Marit Zwierzina Edith Lorenz | 2023/12/31 |
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2 | Catherine Sautes-Fridman Marıa Moreno Leticia Moreno-Fierros Renate Pichler R Pichler | 2023 | |
APRI+ ALBI Score Outperforms Indocyanine Green (ICG) Clearance and LiMAx in Predicting Posthepatectomy Liver Failure–An International Multicenter Study of 14776 Patients | HPB | J Santol S Kim L Gregory AE Kern H Hackl | 2023/1/1 |
An APRI+ ALBI based multivariable model as preoperative predictor for posthepatectomy liver failure | Annals of surgery | Jonas Santol Sarang Kim Lindsey A Gregory Ruth Baumgartner Anastasia Murtha-Lemekhova | 2023/10/20 |
Toll-like receptor 3 mediates aortic stenosis through a conserved mechanism of calcification | Circulation | Can Gollmann-Tepeköylü Michael Graber Jakob Hirsch Sophia Mair Andreas Naschberger | 2023/5/16 |
Prediction of long-term outcome after liver resection based on preoperative evaluation of three MIRS | HPB | D Pereyra H Hackl S Skalicky J Santol A Kern | 2023/1/1 |
Immune infiltrate co-occurrence and neoantigen similarity are prognostic factors in early stage NSCLC | Cancer Research | Martina M Sykora Jason Pugh Bailiang Li Finn O Mildner Hubert Hackl | 2023/4/4 |
Age-Dependent Surface Receptor Expression Patterns in Immature Versus Mature Platelets in Mouse Models of Regenerative Thrombocytopenia | Cells | Anita Pirabe Sabine Frühwirth Laura Brunnthaler Hubert Hackl Anna Schmuckenschlager | 2023/10/8 |
42P Endothelin-1 genetic polymorphism (SNP rs5370-TT) fails to predict resistance to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial | Annals of Oncology | SP Gampenrieder M Steiner C Hufnagl H Hackl G Rinnerthaler | 2022/5/1 |
Impact of glucocorticoid treatment and elevated stromal GR signaling on extracellular matrix remodeling and epithelial compartment interaction with consequences for prostate … | European Urology Open Science | A Eigentler A Degen H Hackl F Handle K Jöhrer-Deym | 2022/10/1 |
